Chronic hepatitis B, a well-known color change disease.

It is reported that there are 93 million hepatitis B virus carriers in China. They not only suffer from the disease, but also suffer from serious discrimination in school and employment. What is chronic hepatitis B really about? Today, Xiao Nuo will show you something.

What is chronic hepatitis B?

Chronic hepatitis B (abbreviated as hepatitis B) refers to those who are positive for hepatitis B virus, whose course of disease is more than half a year, or whose onset date is not clear and whose clinical manifestations are chronic hepatitis.

The clinical manifestations are asthenia, fear of food, nausea, abdominal distention, pain in the liver area and other symptoms. The liver is large, with medium hardness and light tenderness. Patients with severe disease may be accompanied by chronic liver disease, facial features, spider nevus, liver palms, spleen enlargement, and abnormal or persistent liver function.

According to the clinical manifestations, it can be divided into mild, moderate and severe. Chronic hepatitis B carrier refers to those who are positive for hepatitis B virus test and have no symptoms of chronic hepatitis, who have been followed up for more than three times in a year without abnormal serum ALT and AST, and whose liver histology is normal.

2 etiology

Chronic hepatitis B is caused by the infection of hepatitis B virus (HBV). Hepatitis B patients and HBV carriers are the main source of infection.

HBV can be transmitted through mother and infant, blood and blood products, damaged skin and mucous membrane and sexual contact. After HBV infection, there will be different outcomes and clinical types due to the influence of virus factors, host factors and environmental factors.

The common causes leading to the development of chronic hepatitis B are: familial transmission of infectious virus in infancy, lack of awareness of prevention, missed diagnosis, low immune function and previous history of other liver diseases.

3 hazards

The harm of chronic hepatitis B is not small, not only affects the health of patients, but also interferes with their normal life, and causes great psychological harm. Hepatitis B virus exists in the body for a long time, which will continuously damage the liver. The course of disease can develop to cirrhosis, liver cancer, life-threatening. Chronic hepatitis B may also cause other diseases - chronic hepatitis B complications.

Generally speaking, hepatitis B is a silent disease, which happens a lot quietly. Many patients even have cirrhosis and don't know if they have tumors. Secondly, it is a disease that keeps accumulating, so it is very important to check regularly, at least once every six months, to prevent the occurrence of cancer.

4 key points of treatment

The key point of chronic hepatitis B treatment is antiviral treatment, and the purpose of treatment is to inhibit the replication of hepatitis B virus for a long time, slow down liver inflammation and fibrosis, delay liver failure, liver cirrhosis decompensation, and the occurrence of primary liver cancer. So as to improve the quality of life and prolong the survival time. Some patients can achieve the surface antigen turn negative through treatment, and the liver function can return to normal.

The miraculous effect of 5-peptide drugs

With the development of medicine in the world, polypeptide drugs for chronic hepatitis B have been gradually recognized by human beings because of their wide indications, high safety and significant curative effect. The "thymus injection method new" produced by sannuo biology is the application of polypeptide drugs in chronic hepatitis B.

Action mechanism:

Thymosin α can significantly improve the antiviral effect of the body and reduce the rebound phenomenon after drug withdrawal.

Thymosin α 1 can promote the endogenous anti-virus immune response, improve the effectiveness of host cell immune mechanism, and coordinate the immune regulatory function, so as to eliminate HBV infected hepatocytes.

In addition to the treatment of viral hepatitis, thymus method can also be used for the following diseases:

■ various solid and non solid tumors

■ reduce toxic and side effects of chemotherapy and improve tolerance

■ prevention and treatment of infection and infectious diseases

■ enhance the immune response of people with ineffective vaccination

■ rescue of burn, ICU and other critical patients

■ other diseases that need to improve immune function

Shengnuo bio PRODUCT

Best sales manager contact

About Shengnuo

Chengdu Shengnuo Biotechnology Co., Ltd. has "Chengdu polypeptide drug engineering technology research center" in Chengdu, mainly engaged in polypeptide, polypeptide drug and beauty peptide research. Our zero defect has passed the FDA certification, and now it has become the first-class professional peptide drug and product development, technology transfer, technical service and peptide drug industry in the scale production and export of China's parks.